Castle Biosciences's total assets for Q3 2025 were $562.79M, an increase of 3.31% from the previous quarter. CSTL total liabilities were $95.74M for the fiscal quarter, a 7.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.